Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice

Kwangsuk Ko1, Heping Yang, Mazen Noureddin

  • 1Department of Medicine, USC Research Center for Liver Diseases, USC-UCLA Research Center for Alcoholic Liver and Pancreatic Diseases, Keck School of Medicine USC, Los Angeles, CA 90033, USA.

Insights

Endotoxemia depletes glutathione (GSH) by reducing glutamate-cysteine ligase (GCL) expression. S-adenosylmethionine (SAMe) treatment preserves GCL and GSH levels, preventing liver injury during endotoxemia.

Area of Science:

  • Hepatology
  • Biochemistry
  • Immunology

Background:

  • Endotoxemia, triggered by lipopolysaccharide (LPS), is a key factor in liver injury pathogenesis.
  • LPS inactivates hepatic methionine adenosyltransferase (MAT), impacting S-adenosylmethionine (SAMe) biosynthesis.
  • SAMe and glutathione (GSH) are crucial for liver function and protection against injury.

Purpose of the Study:

  • To investigate alterations in SAMe and GSH homeostasis during endotoxemia.
  • To evaluate the protective effects of SAMe pretreatment on LPS-induced liver injury.

Main Methods:

  • Mice were pretreated with SAMe or vehicle, followed by LPS administration.
  • Hepatic SAMe, S-adenosylhomocysteine, GSH levels, and related enzyme expression (MAT, GCL, glycine N-methyltransferase) were measured.
  • Liver injury markers (plasma alanine transaminases) and cytokine mRNA levels were assessed.

Main Results:

  • LPS unexpectedly increased hepatic SAMe levels and MAT expression but inhibited MAT activity.
  • LPS significantly decreased hepatic GSH levels, correlating with reduced glutamate-cysteine ligase (GCL) expression.
  • SAMe pretreatment prevented GSH depletion by preserving GCL expression and protected against liver injury.

Conclusions:

  • The liver upregulates methionine adenosyltransferase (MAT) expression but inhibits its activity and SAMe utilization during endotoxemia.
  • Glutathione (GSH) depletion in endotoxemia is primarily due to decreased glutamate-cysteine ligase (GCL) expression.
  • S-adenosylmethionine (SAMe) treatment mitigates liver injury by preserving GCL expression and maintaining GSH levels.

Related Concept Videos